Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...
By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...
OS of 8.9 months versus 5.8 months with trifluridine/tipiracil alone, supporting phase III ...